Supplement quality testing: the specification, the certificate and each test

In short

  • Each batch is tested against the finished product's specification: its formula, form and pack, the sampling and test methods, the acceptance limits, the storage conditions and the shelf life.
  • A certificate of analysis summarises a batch's results and evaluates them against the specification. No batch is released for sale until an authorised person certifies it.
  • Testing is a licensed step. A listing names a manufacturer for chemical and physical testing and for microbial testing, and each needs a TGA licence or clearance for the step.
  • A listed tablet or capsule meets TGO 101 (assay, uniformity of weight, disintegration or dissolution, elemental impurities), and a medicine meets TGO 100's microbiological limits.
  • The standards apply throughout the shelf life, so an ongoing stability program keeps testing after release.

The specification

Under the GMP code, a finished product's specification sets out its formula, its form and pack, the directions for sampling and testing, the acceptance limits, the storage conditions and the shelf life. Test results are formally assessed against it before a batch is released.

It is written before the first order, and it is the document every later argument comes back to: whether a batch passes, whether a supplier's ingredient is acceptable, whether a change needs a new study. A sponsor may set release limits tighter than the TGA's standards. When we manage manufacturing, we write the specification with the formula (managed manufacturing).

The certificate of analysis

A certificate of analysis summarises the results of testing for a batch, with its evaluation against the stated specification. Ask for one with every batch, check that it names the batch and the specification version, and keep it with the batch records: it is the evidence that the batch you sold met its specification.

The tests

Tablets and capsules: TGO 101. Unless it follows an applicable pharmacopoeia monograph, a listed tablet or capsule meets the order's own requirements:

Test What it checks
Assay Each active ingredient within limits of its label claim: 90.0 to 120.0% by default; wider for vitamins (up to 90.0 to 175.0%), minerals (90.0 to 160.0%, or 90.0 to 125.0% for boron, chromium, fluorine, iodine, molybdenum and selenium) and enzymes (90.0 to 200.0%); probiotics not less than the stated content. A pooled sample of at least 20 units.
Uniformity of weight That units are consistent in mass
Disintegration That a tablet or capsule breaks up as it should; chewables are exempt
Dissolution Instead of disintegration, for modified-release products and most with 100 micrograms or more of folic acid
Elemental impurities and residual solvents Limits under the ICH Q3D guideline or the US pharmacopoeia, and the European pharmacopoeia

More on the format-specific rules in our guides to tablets, capsules and softgels.

Microbes: TGO 100. A complementary medicine taken by mouth that contains raw material of natural origin, animal, vegetable or mineral, must meet the acceptance criteria in Schedule 1 of TGO 100 (a herbal tea made with boiling water meets Schedule 2 instead): limits on total aerobic microbes, yeasts and moulds and bile-tolerant gram-negative bacteria, and no Salmonella, E. coli or Staphylococcus aureus in the amount tested.

Not every test on every batch. A medicine must comply with TGO 101 throughout its shelf life, but the TGA says not every test must be run on every batch: the design of the medicine, its control strategy and its validation or stability data can show the standard will be met. Which tests run on every batch is written into the specification and agreed with the manufacturer.

Who tests and who releases

Testing is a licensed step. When a sponsor lists a medicine, it names a manufacturer for each of five steps, two of them testing: chemical and physical testing, and microbial testing. The TGA's listing system won't validate the listing unless each manufacturer's licence or clearance matches its step, so the laboratory that tests your batch needs a licence or clearance for testing, like the factory that makes it (choosing a supplement manufacturer).

Release for supply. It is the step at which a batch is certified for sale, carried out by an authorised person of a TGA-approved manufacturer, who certifies that each batch has been made and controlled in line with the medicine's marketing authorisation. Under the GMP code, no batch is released before that certification.

The GMP agreement sets out who does each test, which tests run on every batch, and how deviations and out-of-specification results are reported.

After release: stability

The standards apply until the expiry date, not only on the day of release. An ongoing stability program tests the product, stored as its label says, at set points through its shelf life: each active ingredient claimed on the label, physical tests including pack integrity, and microbiological tests at least at the start and end. What the TGA expects, and what happens when a result fails, is in our stability testing guide. A batch that fails in the market may need a recall or a correction (product recalls).

Foods and cosmetics

A supplement sold as a food isn't tested to TGO 101 or TGO 100: it follows the Food Standards Code. A cosmetic follows good manufacturing practice under ISO 22716. Settle the pathway first (medicine, food or cosmetic?).

From our records

  • Every listed batch tested. Every TGA-listed batch we manage is third-party tested before release. For The Belly Solution we managed manufacturing, release testing and delivery, with a 36-month stability program.
  • A three-year expiry designed in. For an eye-health tablet we designed the stability protocol to support a three-year expiry.
  • Stability at set points. BWellness's tablet has a stability program at 3 and 12 months, and an eye-health formula a 24-month program.

Questions

Frequently asked questions

A listed tablet or capsule meets TGO 101 (assay, uniformity of weight, disintegration or dissolution, and elemental impurity limits), and a medicine meets TGO 100's microbiological limits, against the product's own specification.

A summary of the test results for a batch, with their evaluation against the product's specification. Ask for one with every batch.

For a listed medicine, chemical and physical testing and microbial testing are licensed steps: the laboratory needs a TGA licence, or a GMP clearance overseas, that covers the step.

Not always. The TGA says a medicine's design, control strategy and validation or stability data can show the standard will be met without running every test on every batch. The specification says which tests run each time.

An authorised person of a TGA-approved manufacturer licensed for release for supply, who certifies the batch before it is sold.

Sources

General information, checked against these sources on 18 November 2026. It isn't advice on a particular product. Our work is from Take Friday Off's records.

Close your laptop on Thursday night and relax.

Your launch keeps moving, in hands that care about it as much as you do. That's The Friday Feeling™.

15 minutes, no obligation, and a clear next step either way.

Questions first? Read the questions brands ask us